MeCP2 links heterochromatin condensates and neurodevelopmental disease.

TitleMeCP2 links heterochromatin condensates and neurodevelopmental disease.
Publication TypeJournal Article
Year of Publication2020
AuthorsLi CH, Coffey EL, Dall'Agnese A, Hannett NM, Tang X, Henninger JE, Platt JM, Oksuz O, Zamudio AV, Afeyan LK, Schuijers J, X Liu S, Markoulaki S, Lungjangwa T, LeRoy G, Svoboda DS, Wogram E, Lee TIhn, Jaenisch R, Young RA
JournalNature
Volume586
Issue7829
Pagination440-444
Date Published2020 Oct
ISSN1476-4687
KeywordsAdaptive Immunity, Animals, Female, Heterochromatin, Immunity, Innate, Intellectual Disability, Methyl-CpG-Binding Protein 2, Mice, Mutation, Neurons, Phenotype, Rett Syndrome
Abstract

Methyl CpG binding protein 2 (MeCP2) is a key component of constitutive heterochromatin, which is crucial for chromosome maintenance and transcriptional silencing1-3. Mutations in the MECP2 gene cause the progressive neurodevelopmental disorder Rett syndrome3-5, which is associated with severe mental disability and autism-like symptoms that affect girls during early childhood. Although previously thought to be a dense and relatively static structure1,2, heterochromatin is now understood to exhibit properties consistent with a liquid-like condensate6,7. Here we show that MeCP2 is a dynamic component of heterochromatin condensates in cells, and is stimulated by DNA to form liquid-like condensates. MeCP2 contains several domains that contribute to the formation of condensates, and mutations in MECP2 that lead to Rett syndrome disrupt the ability of MeCP2 to form condensates. Condensates formed by MeCP2 selectively incorporate and concentrate heterochromatin cofactors rather than components of euchromatic transcriptionally active condensates. We propose that MeCP2 enhances the separation of heterochromatin and euchromatin through its condensate partitioning properties, and that disruption of condensates may be a common consequence of mutations in MeCP2 that cause Rett syndrome.

DOI10.1038/s41586-020-2574-4
Alternate JournalNature
PubMed ID32698189
PubMed Central IDPMC7735819
Grant ListR01 GM123511 / GM / NIGMS NIH HHS / United States
T32 GM007287 / GM / NIGMS NIH HHS / United States
R01 MH104610 / MH / NIMH NIH HHS / United States
2 R01 MH104610-20 / NH / NIH HHS / United States
K99 MH113813 / MH / NIMH NIH HHS / United States
T32 GM087237 / GM / NIGMS NIH HHS / United States
R00 MH113813 / MH / NIMH NIH HHS / United States
R37 CA084198 / CA / NCI NIH HHS / United States
T32 5T3DK007191-45 / NH / NIH HHS / United States
T32 DK007191 / DK / NIDDK NIH HHS / United States